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Mouse model of smallpox
Virulence factor
Attenuation of cowpox virusof mice with cowpox virus (CPXV), is lethal at a lower dose than intranasal (i.n.)
inoculation. CPXV deleted for cytokine response modiﬁer A (CPXVΔcrmA) was attenuated compared to CPXV
after i.t. inoculation. This attenuation could not be attributed to differences in virus replication,
immunomodulators, or cells inﬁltrating the lungs. Deletion of crmA also caused attenuation during
intradermal (i.d.) infection. In contrast to i.t.-inoculated virus, deletion of crmA reduced virus replication at
the site of infection. This difference correlated to increased numbers of CD3+ cells in CPXVΔcrmA-associated
dermal lesions. Thus, crmA is a virulence factor in mice during either pulmonary or dermal cowpox infection;
however the inﬂuence of crmA is more evident during i.d. inoculation. This suggests that the host immune
response differs in the two routes of infection and emphasizes the need to consider the effect of route of
infection when examining functions of virulence factors in vivo.
© 2008 Elsevier Inc. All rights reserved.Introduction
Smallpox is a dreaded, often fatal, human viral disease hallmarked
by severe skin lesions and pneumonia (Fenner,1984). A similar disease
is caused by monkeypox virus, which is indigenous in equatorial
Africa. Although smallpox has been eradicated through extensive
vaccination of the human population, there is strong interest in
improving current animal models of smallpox infection. In this
manner, the disease can be studied indirectly and new control
methods developed in the event that the causative agent of smallpox
(variola virus) is released into the environment (Ferrier-Rembert et al.,
2007) or to control emerging humanmonkeypox virus infections. Due
to the human-speciﬁc nature of variola virus, other related Ortho-
poxviruses, such as zoonotic cowpox virus (CPXV), have been utilized
as surrogate model viruses. Since rodents (particularly voles and
woodmice) are thought to be reservoir hosts of CPXV (Chantrey et al.,
1999), mice infected with CPXV have been used to evaluate host/
pathogen interactions. Mouse models are clearly advantageous
because of the excellent characterization of most mouse strains, thel rights reserved.availability of transgenic mice and a variety of mouse-speciﬁc
immunologic reagents, and their relatively inexpensive maintenance.
A natural infection by CPXV typically results from introduction of
virus into the skin and usually produces mild disease unless the host is
immunosuppressed. Variola virus is typically introduced via aero-
solized particles or dermal inoculation. In human dermal infections,
there is approximately a seven day incubation period after exposure to
CPXV or variola virus before fever and ﬂu-like symptoms begin
(Breman and Henderson, 2002; Lewis-Jones, 2004). In both cowpox
and smallpox infections, papules that form in the skin at the site of
inoculation develop into black eschars surrounded by edema and
erythema. The lesions become covered by scabs which then shed
leaving a scar. In the case of variola virus, virus particles commonly
spread throughout the body. Replication of variola virus in the lung
leads to severe pneumonia and difﬁculty with oxygenation and
ventilation. Respiratory compromise, along with dehydration due to
ﬂuid loss through breaks in the skin (leading to shock and renal
failure), are the most likely causes of death in smallpox victims
(Martin, 2002). In contrast, CPXV replication in humans is usually
limited to skin lesions at the site of introduction. However, there are
rare cases of human CPXV infection, where virus from the initial site of
infection in the skin spreads to and replicates in the lungs, resulting in
mortality due to complications of viral pneumonia (Hawranek et al.,
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naturally infected with CPXV (Nitsche et al., 2007).
Typically, experimental infection of mice with CPXV has been
designed to result in the afﬂicted animals exhibiting signs of systemic
disease and experiencing pneumonia; conditions similar to those
caused by variola virus in humans. To produce such pulmonary
disease in immunocompetent mice, large doses of CPXV are
administered directly to their respiratory system by aerosolized or
intranasal (i.n.) inoculation. Although aerosolization is usually
effective (Martinez et al., 2000), there are inherent problems with
the procedure including the need for specialized equipment that
enables adequate suspension of the virus, a required size of the
aerosolized particles for efﬁcient uptake by themice, and the potential
for environmental contaminationwith the virus. While the practice of
i.n. inoculation avoids the concerns associated with virus aerosoliza-
tion, the desired outcome of pulmonary disease is not always
achieved. Instead, in the study by Martinez et al. (2000), only half of
themice infected i.n. developed pulmonary disease, but all of themice
had severe rhinitis and sinusitis (which likely contributed to death).
Moreover, as with application of aerosolized virus, exact dosage of the
pathogen is difﬁcult to achieve during i.n. exposure due to variable
reﬂux, expulsion, and loss of the inoculum to the overall surroundings
and immediate external area (fur) of the treated animal.
In addressing the need for a reliable representation of smallpox in
mice, we decided to evaluate intratracheal (i.t.) inoculation as a novel
method for poxvirus introduction into this animal. This approach
ensures that a more precise number of viral particles are distributed
throughout the lower respiratory tract by bypassing the nasal and
oral cavities and avoids the technical difﬁculties associated with
aerosol and i.n. inoculations. We chose to infect C57BL/6 mice in lieu
of the BALB/c strain traditionally used to examine poxvirus
pathogenesis because of differences in important facets of their
immune systems. Speciﬁcally, the latter does not mount strong cell-
mediated immune responses against viral infection (Janeway et al.,
1999) and has a less active complement system due to lower
production of the complement protein C3 (Dieli et al., 1988). In
addition, future studies would beneﬁt from utilizing C57BL/6 mice as
this strain is more commonly used as a progenitor for commercially
available transgenic mice.
We also performed a comparative assessment of the disease which
resulted from intradermal (i.d.) inoculation of mice via the ear pinnae;
a method ﬁrst described by Tscharke et al. (2002). Intradermal
infections more closely mimic the typical natural route of CPXV
transmission and dermal models of poxvirus infection have been
implemented to test the effectiveness of smallpox vaccines (Melamed
et al., 2007). Both i.t. and i.d. models utilize natural routes of poxvirus
infection (into the lung or skin respectively), but i.d. infection of mice
with CPXV fails to produce the severe pulmonary infection reported
after i.d. inoculation of humans with variola virus. In experiments
with the closely related Orthopoxvirus, vaccinia virus (VACV), it
appears that there are marked differences in the immune response to
i.d. inoculation of mice compared to the response following i.n.
inoculation (Tscharke et al., 2002). We sought to determine if this also
was the case with CPXV infection and we have compared the
pathogenesis of CPXV infection after i.d. inoculation to the i.t. model.
We also compared wild type (wt) CPXV and a mutant of CPXV
which lacked the gene encoding cytokine response modiﬁer A (crmA)
referred to as CPXVΔcrmA (Nathaniel et al., 2004). The crmA protein is
a serine proteinase inhibitor (serpin) that inhibits the serine
proteinase granzyme B (Quan et al., 1995) as well as group 1 and 3
cysteine aspartyl-speciﬁc proteinases (caspases) (Garcia-Calvo et al.,
1998). Thus, in vivo, crmA complex formation with caspase-1 may
prevent the processing of soluble interleukin-1β (IL-1β) and IL-18;
absence of these mediators would lead to decreased inﬂammation at
the site of infection and reduce activation of cell-mediated cytotoxi-
city. Furthermore, the predicted crmA inhibition of granzyme B,caspase-8, -9, and -10 activity would limit apoptosis of virus-infected
cells and hence, enable more efﬁcient replication of the virus.
The crmA gene is highly conserved in a variety of other poxviruses
(Smith et al., 1989) and in VACV is referred to as ‘SPI-2’ or B13R.
Although the importance of crmA expression during CPXV infection
has not been established in immunocompetent animals, this protein
has been demonstrated to be a virulence factor when CPXVwas grown
in the chorioallantoic membranes of developing chicken embryos
where CPXVΔcrmA producedwhite pocks rather than the red pocks of
wt CPXV (Nathaniel et al., 2004; Pickup et al., 1984; Palumbo et al.,
1994; Ray et al., 1992).
Interestingly, we found only a relatively small difference in the
degree of pathogenesis associated with the wt CPXV and crmA-
deﬁcient CPXV (CPXVΔcrmA) when the twowere compared following
i.t. inoculation. However, differences between the two viruses were
more obvious when the i.d. route was used. Speciﬁcally, CPXVΔcrmA
infections led to a greater inﬂux of CD3+ mononuclear cells in the skin
with elimination of the virus by 16 days post inoculation (dpi),
whereas high amounts of wt CPXV could be isolated at this time point.
We were also able to demonstrate that i.t. inoculation of C57BL/6 mice
with CPXV resulted in viral pneumonia with a disease course
analogous to smallpox in humans.
Results
Effect of crmA on the terminal caspase activity of CPXV-infected
cultured cells
Previously, crmA was found to block apoptosis in CPXV-infected
porcine cells (Ray and Pickup, 1996) presumably by inhibiting two
initiators of this cell-death process, namely caspases-8 and -10
(Garcia-Calvo et al., 1998; Zhou et al., 1997). More recently, it was
shown that CPXVΔcrmA, unlike wt CPXV, fails to inhibit apoptosis in
infected chorioallantoic membranes of developing chicken embryos
based on its inability to prevent activation of terminal caspases-3 and
-7 (Nathaniel et al., 2004). To ensure that this deﬁciency of
CPXVΔcrmA was attributed only to a genetic loss of the crmA gene,
a rescue mutant (rCPXV) was derived from this recombinant and
assessed for its ability to preclude apoptosis. The extent of cleavage of
the caspase substrate Ac-DEVD-aminomethylcoumarin (AMC) in
lysates of CPXV- and rCPXV-infected porcine renal epithelial (LLC-
PK1) cells was similar to that achieved in uninfected cells (all less than
1 ﬂuorescence unit/s). In contrast, a greater than 10-fold increase in
caspase activity was detected in the CPXVΔcrmA-infected cells (19.15
ﬂuorescence units/s). Thus, as expected, expression of crmA was
sufﬁcient for CPXV-directed inhibition of caspase activation and
apoptosis in infected cells.
Effect of crmA on the virulence of CPXV intratracheally inoculated
into mice
The reported lethal dose of half (LD50) of BALB/c mice after i.n.
inoculation with CPXV is 2×105 plaque-forming units (pfu)/mouse
(Thompson et al., 1993). In comparison, C57BL/6 mice were markedly
more sensitive to i.t. inoculation of CPXV as the effective LD50 for
these conditions was approximately 100-fold lower at 3.2×103 pfu/
mouse. Accordingly, for assessing the effect of crmA on CPXV
virulence in vivo, C57BL/6 mice were i.t.-inoculated with 104 pfu of
CPXV, CPXVΔcrmA, or rCPXV and monitored for signs of distress. By
15 dpi, at least half of the CPXV- or rCPXV-infected mice were
euthanized, whereas only approximately 20% of those inoculated
with CPXVΔcrmA had to be terminated (Fig. 1). Moreover, the onset of
disease signs such as weight loss, hunched posture, breathing
difﬁculty, hypothermia, dependent edema, lethargy, poor grooming,
abdominal distention, and (rarely) pock development on non-haired
skin was more rapid and more pronounced in the CPXV- and rCPXV-
Fig. 1. Survival rate. Cumulative survival of C57BL/6 mice after i.t. inoculation of 30 μL
PBS (n=12), 104 pfu CPXV (n=22), 104 pfu CPXVΔcrmA (n=22), or 104 pfu rCPXV (n=19).
Results are the composite of three experiments. Error bars represent standard error.
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crmA expression appeared to somewhat attenuate CPXV in C57BL/6
mice.
The pathology of intratracheal CPXV infections in mice and the effect
of crmA
Cytological examination of bronchoalveolar lavage (BAL) ﬂuid
collected from the lungs of uninfected, CPXV-, and CPXVΔcrmA-
infected C57BL/6 mice indicated an initial incidence of mild mono-
nuclear inﬂammation in the lower respiratory tract at 1 dpi compared
to 0.5 dpi. Since this event was a common feature in all experimental
groups and the inﬂammation cleared by the second dpi, it probably
represented a non-speciﬁc host response to the trauma of adminis-
tration of 30 μL of ﬂuid into the lungs. It was not until 9 to 11 dpi that a
second round of inﬂammation was detected in BAL ﬂuid of infected
mice but not phosphate buffered saline (PBS)-inoculated mice. The
severity of inﬂammation was similar both in CPXV- and CPXVΔcrmA-
infected mice (data not shown).
Hematoxylin and eosin (H&E)-stained sections of lungs were
evaluated for the presence of inﬂammation, hemorrhage, edema,
necrosis, and ﬁbrosis. Alterations were not observed in any lung
samples obtained at 1 and 4 dpi. However by 7 dpi (Fig. 2) and
thereafter, the majority of virus-infected mice had mild to moderate,
multifocal, mixed (predominantly mononuclear) inﬂammation that
tended to be focused around the bronchioles. The degree of bronchiolar
epithelial hyperplasia and necrosiswasmoderate to severewith several
bronchioles being affected. Generally, there was mild to moderate,
multifocal, vascular necrosis and occasionally mild to moderate
hemorrhage and edema (often associated with areas of vascularFig. 2. Histopathology of lung sections. Representative lung sections from mice 7 d afte
magniﬁcation).necrosis). Thus, the lesion characteristics were consistent with a
diagnosis ofmoderate to severe viral bronchopneumonia characterized
by mononuclear inﬂammation, bronchiolar hyperplasia, and necrosis.
As expected, due to differences in sample collection, inﬂammation
was detected in the lung sections before it was observed in the BAL
ﬂuid. In both the sections of lung and the BAL ﬂuid, the cellular
characteristics of the inﬂammation observed were similar when
comparing the lungs of mice infected with CPXV or CPXVΔcrmA.
However, the severity of the lung lesions was slightly greater in
animals infected with CPXV and this difference directly corresponded
to the severity of clinical signs seen in these mice. Neither signs of
disease nor histologic lesionswere observed in the lungs of the control
(PBS-inoculated) mice (Fig. 2).
Lesions were not observed in the brain of any mouse inoculated i.t.
with PBS. In contrast, a mild focal lymphocytic inﬁltrate was noted in
the cranial aspect of the brain in 1mouse at 2 dpi and 1mouse at 4 dpi
from each of the CPXV and the CPXVΔcrmA experimental groups. A
small lesion also was observed in 1 CPXVΔcrmA-infectedmouse 7 dpi.
The severity of clinical signs had no correlation to any brain lesions in
either CPXV or CPXVΔcrmA i.t.-infected mice.
Tissue sections derived from heart, thymus, liver, spleen, kidney,
gastrointestinal tract, and reproductive tract were unremarkable
regardless of virus titer in the organ. On Day 7 post inoculation, 2 of
5 CPXV-infected animals had inﬂammation and necrosis in the nasal
turbinates; viral inclusions were observed in secretory epithelial cells
of 1 of these mice. Also, 1 of 5 CPXVΔcrmA-infected animals had mild
hemorrhage in the epidermis and dermis of the nasal mucosa 7 dpi.
These ﬁndings indicate that i.t. inoculation of mice with 104 pfu of
CPXV reproducibly causes bronchopneumonia, which is the cause of
death in infected mice. The limited involvement of other organ
systems (including brain and nasal mucosa) indicates that i.t.
inoculation more accurately models smallpox pathogenesis than
virus administered via the i.n. route. The effects of deleting the
crmA gene on the pathology of the infection were detectable but
minimal.
Effect of crmA on the virus replication in mice after intratracheal
inoculation of CPXV
To determine the effects of deleting crmA on virus growth in
mouse tissues, the virus titers within internal organswere determined
from Day 0.5 through 15 post infection (Table 1). Tissues collected
from i.t.-inoculated mice included lung, brain, liver, heart, spleen,
kidney, intestine, and reproductive tract. Virus was detected in each of
these organ systems, however only the lung and brain consistently
contained detectable virus. Virus alsowas consistently recovered from
BAL ﬂuid collected from infected animals after euthanasia. Statistically
signiﬁcant differences in virus titer were not observed when
comparing CPXV and CPXVΔcrmA infections. This indicates that
deletion of crmA from CPXV does not affect the ability of the virus to
replicate and spread after i.t. inoculation. Interestingly, increases in
virus titer in tissue and BAL ﬂuid samples did not correlate to an
increase in clinical disease signs in the infected mice.r i.t. inoculation with 30 μL PBS, 104 pfu CPXV, or 104 pfu CPXVΔcrmA (H&E; 200×
Table 1
Average virus titer from organs after intratracheal inoculation of micea
Days post inoculationb
1 4 7 11 15
CPXV CPXV ΔcrmA CPXV CPXV ΔcrmA CPXV CPXV ΔcrmA CPXV CPXV ΔcrmA CPXV CPXV ΔcrmA
Lung 4.1 b4.0 6.2 6.2 7.0 7.1 5.5 7.2 6.7 7.5
BAL b4.0 b4.0 8.4 7.3 7.0 7.6 7.3 7.9 6.2 5.0
Brain nvi nvi 4.8 b4.0 5.6 5.3 6.2 b4.0 b4.0 b4.0
Liver nvi nvi nvi nvi 4.8 b4.0 nd nd nd nd
Heart nvi nvi nvi nvi nvi b4.0 nd nd nd nd
Spleen nvi nvi nvi nvi b4.0 b4.0 nd nd nd nd
Kidney nvi nvi nvi nvi nvi b4.0 nd nd nd nd
Intestine nvi nvi b4.0 nvi nvi nvi nd nd nd nd
Ovary nvi nvi nvi nvi b4.0 4.0 nvi nvi b4.0 b4.0
Abbreviations: BAL = bronchoalveolar lavage ﬂuid; nvi = no virus isolated; nd = not determined.
a C57BL/6 mice were inoculated intratracheally with 30 μL of PBS containing 104 plaque-forming units (pfu) of the indicated virus. Organs were collected at necropsy, ﬂash-frozen
in liquid nitrogen, and then stored at −80 °C until virus titers were determined. Four to ten mice were used for each experimental group.
b The virus titer isolated from the indicated organs is represented as the logarithm of the average pfu per gram of tissue. Virus was isolated from at least one mouse per group in
organs with virus titers b4.0, but the average titer for the group was less than the limit of detection for the assay (approximately 10,000 pfu per gram of tissue).
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Inhibition of apoptosis by crmA has been associated with increased
CPXV replication in the chorioallantoic membranes of developing
chicken embryos (Nathaniel et al., 2004). To determine if crmA
negatively regulated apoptosis during CPXV infection of mice without
impacting the efﬁciency of virus replication, terminal deoxynucleo-
tidyl transferase mediated dUTP nick-end labeling (TUNEL) of lungs
and mediastinal lymph nodes from CPXV- and CPXVΔcrmA-infected
mice was performed. Evidence of cell death was seen in all necrotic
regions of the lungs and greater quantities of TUNEL-positive cells
were observed in the mediastinal lymph nodes that drained the
necrotic lesions. Although apoptosis was more readily detected in
tissue from the infected mice compared to PBS-inoculated animals, a
signiﬁcant difference in this parameter was not observed between
mice infected with CPXV compared to CPXVΔcrmA-infected animals
(data not shown).
Effect of crmA on the cytokine and chemokine response of mice to
intratracheal inoculation with CPXV
A temporal comparison of the serum concentrations of 18
immunomodulators in mice during the 15-day period after i.t.
inoculation with PBS, CPXV, or CPXVΔcrmA indicated that statisti-
cally signiﬁcant changes occurred for only four of these immuno-
modulators; namely IL-6, IL-10, keratinocyte-derived chemokine
(KC), and IL-1β. Immune mediators were quantiﬁed using a Mouse
Cytokine 18-Plex Panel (Bio-Rad Laboratories Inc., Hercules, CA). As
seen in Fig. 3A, the quantity of circulating IL-6 was approximately
three-fold greater in CPXV-infected mice compared to PBS control
animals at 7 dpi (P-valueb0.0001) and at least two-fold greater
compared to CPXVΔcrmA-inoculated mice at 7 dpi (P-value=0.0003)
and 9 dpi (P-value=0.0022). A similar enhancement of the amount of
IL-10 (approximately 3-fold) was noted in the CPXV-inoculated mice
at 7 dpi (Fig. 3B) compared to PBS or CPXVΔcrmA-inoculated
animals (P-valuesb0.0001). Fig. 3C graphs serum KC levels; at 7 dpi,
KC was increased 2 to 3-fold in CPXV- and CPXVΔcrmA-infected
mice compared to PBS controls (P-valuesb0.0001 and =0.0023,
respectively). It is interesting to note that the levels of KC were
increased in all mice at 0.5 dpi, which may reﬂect the inﬂammation
observed in BAL samples at this time point. IL-1β was increased 10-
fold in CPXV-infected mice at 0.5 dpi compared to PBS- and
CPXVΔcrmA-inoculated animals (P-values≤0.0003). However the
concentration of IL-1β in CPXV-infected mice at 0.5 dpi did not
exceed levels of IL-1β in mock-infected animals at 7 or 15 dpi and sois unlikely to be physiologically signiﬁcant (Fig. 3D). The systemic
levels of the other 14 tested immunomodulators in sera remained
fairly constant regardless of how the mice had been treated.
BAL samples also were tested using the Mouse Cytokine 18-Plex
Panel in attempt to quantitate local levels of immunomodulators in
pulmonary tissue. At 7 dpi, the relative quantities of IL-1α, IL-1β,
macrophage inﬂammatory protein-1α (MIP-1α), and KC in the BAL
ﬂuid from the CPXV-infected mice was increased compared to that of
PBS- or CPXVΔcrmA-inoculated animals, however none of these
differences were found to be statistically signiﬁcant (data not shown).
The levels of IL-1β, IL-18, IL-10, IL-6, and KC were determined in
the lungs using standard enzyme-linked immunosorbant assays
(ELISAs). Signiﬁcant increases in IL-1β and IL-18 levels did not occur.
The increase in IL-10 observed at 7 dpi in serum was not detected in
lung. On Day 7 post inoculation, IL-6 levels in CPXV-infected mice
were 5832 pg/g of tissue, which was signiﬁcantly greater compared to
mice inoculated with PBS (1081 pg/g, P-value=0.0041) or CPXVΔcrmA
(1366 pg/g, P-value=0.0067). Likewise KC concentrations were
signiﬁcantly higher in CPXV-infected mice (880 pg/g) compared to
mice inoculated with PBS (89 pg/g, P-valueb0.0001) or CPXVΔcrmA
(239 pg/g, P-value=0.0009).
Effect of crmA on the virulence of CPXV intradermally inoculated
into mice
Although elimination of the crmA gene slightly attenuated the
resultant recombinant CPXV when i.t.-inoculated into mice, an
obvious cause for this loss of virulence (such as increased inﬂamma-
tion in the lungs, decreased apoptosis of infected cells in the lungs, or
reduced virus replication) was not apparent. Therefore, in an attempt
to discern an in vivo function for crmA, we introduced CPXV and
CPXVΔcrmA into the ear pinnae by i.d. inoculation since dermal
infections represent the natural route of infection with CPXV. An
initial appraisal of the relationship between lesion severity and dose
dependency indicated that the recombinant was somewhat attenu-
ated at doses between 103 and 106 pfu/mouse (data not shown). Based
on this assessment, subsequent experiments utilized inocula contain-
ing 105 pfu virus to ensure differentiation of the two viruses. At this
dosage, as exempliﬁed by the clinical scores presented in Table 2 and
the appearance of the infected ear pinnae in Fig. 4, CPXVΔcrmA was
less pathogenic than CPXV.
Fig. 4 depicts the lesions seen at 4, 8, and 12 dpi. Redness was
observed in all infected mice at 4 dpi. The ear pinnae of CPXV- and
rCPXV-infected mice are markedly red and swollen at 8 dpi; whereas
ear pinnae are red, but not swollen, in CPXVΔcrmA-infected mice. On
12 dpi, ear pinnae of CPXV- and rCPXV-infectedmice remainmarkedly
Fig. 3. Serum concentrations of immune mediators. Serumwas collected at 0.5, 1, 4, 6, 7, 9, 10, 11, and 15 d after i.t. inoculation with 30 μL of 104 pfu CPXV or CPXVΔcrmA. The serum
concentrations of these cytokines in uninfectedmice were also detected at 0.5, 1, 4, 7, and 15 d after i.t. inoculationwith 30 μL of PBS. Levels of immunemediators were detected using
Mouse Cytokine 18-plex Panels. Serum IL-6 (A), IL-10 (B), KC (C), and IL-1β (D) levels are shown. Results of groups of 4 to 5 mice from 4 experiments were averaged. Error bars
represent standard error of the mean. ⁎Statistically signiﬁcant differences (see text).
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CPXVΔcrmA-infected ear pinnae lesions have nearly resolved. Ear
pinnae lesions from wt CPXV- and rCPXV-infected mice still were
visible 15 dpi in approximately 60% of the inoculated mice and, in 2
cases, full-thickness tissue damage that led to loss of the infected ear
pinnae occurred. Virus spread to secondary sites was observed at
12 dpi in 1 CPXV-infected mouse and 1 CPXVΔcrmA-infected mouse.
However, signs of systemic illness (such as weight loss and poor
grooming) were not noted in any experimental group (data not
shown).
Effect of crmA on the histopathology observed in mice after intradermal
inoculation of CPXV
Histological examination of ear pinnae from mice infected with
either CPXV or CPXVΔcrmA revealed extensive edema and mono-
nuclear inﬂammationwithmild ﬁbroblast reactivity at 4 dpi. AlthoughTable 2
Gross pathology of ear pinnae after intradermal injection of micea
Days post inoculationb,c
4 8 12 15
CPXV 0.42 (59) 1.36 (50) 1.91 (32) 2.13 (23)
CPXVΔcrmA 0.44 (59) 0.96 (50) 1.19 (32) 0.83 (23)
rCPXV 0.67 (15) 1.97 (15) 1.87 (15) 2.27 (15)
a C57BL/6 mice were inoculated intradermally with 50 μL of PBS containing 105
plaque-forming units of the indicated virus.
b Pathogenesis represented by the average clinical score as determined by numerical
assessment of the severity of lesions where 1=redness; 2=ulcers/scab; and 3=redness
+ulcers/scab. Scores for treatment were summed and divided by the maximum,
obtainable value (number of mice in group×3) to provide an average clinical score.
c The number of mice monitored at each timepoint is indicated in parentheses.dermal ulceration was observed in approximately two-thirds of the
samples from either type of virus-infected mouse by 8 dpi, lesions
were more severe in the pinnae from CPXV-inoculated animals. By
16 dpi, necrotizing lesions still persisted on 75% of CPXV-infectedmice
compared to only half of the CPXVΔcrmA-infected animals (data not
shown).Fig. 4. Representative images of ear pinnae. Ear pinnae of C57BL/6 mice were infected
i.d. with 105 pfu CPXV or CPXV recombinant viruses at 4, 8, and 12 dpi.
Fig. 5. Virus replication in the ear pinnae. The ears of micewere collected 4, 8, and 16 dpi
with 50 μL PBS (right ear) and 105 pfu CPXV or CPXVΔcrmA (left ear). Results are
presented as the average number of pfu per gram of ear pinnae (n=3 to 11 mice per
group). Error bars represent standard deviation.
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Titration of infectious virus in ear pinnae samples from CPXV or
CPXVΔcrmA i.d.-inoculated mice followed the pattern observed in the
above-mentioned histological assessment. While a large amount of
infectious virus was recovered from CPXV and CPXVΔcrmA-infected
ears at 4 and 8 dpi, by 16 dpi only wt virus could be detected (Fig. 5).
The enhanced clearance of CPXVΔcrmA could not be attributed to an
increased number of apoptotic cells in the adjacent, draining
lymphoid tissue as differences were not observed in the number of
7-amino-actinomycin D (7-AAD) positive cells by ﬂow cytometry
(data not shown).
Characterization of cell populations in lymphoid tissues of mice after
intradermal infection
Cytokine levels were not examined in the i.d. mouse model due to
lack of systemic disease signs. Instead, the phenotype of cells inFig. 6. Average number of CD3+ cells per 100× magniﬁed ﬁeld in lesions of mouse lung (A) an
standard error of the mean. ⁎P-value of cells in CPXV- versus CPXVΔcrmA-infected mice=0various lymphoid tissues was evaluated. To determine if mice cleared
i.d. infection with CPXVΔcrmA more quickly than with CPXV because
of a more effective response by cytotoxic T cells, natural killer (NK)
cells, or NKT cells; these cell populations were evaluated in the
mandibular lymph nodes (which drain the ear pinnae), inguinal
lymph nodes, and spleen.
As expected, given the lack of systemic disease, differences were
not observed in the cell populations from the spleen or inguinal lymph
nodes at any time point after PBS, CPXV, or CPXVΔcrmA inoculation.
Interestingly, when compared to cell counts from PBS-inoculated
mice, a relative increase in activated CD4+ cells (3-fold or more), CD8+
cells (4-fold or more), and NK cells (7-fold or more) was observed in
mandibular lymph nodes of all infected mice; however statistical
signiﬁcance was not reached (data not shown).
Effect of crmA on the inﬁltration of CD3+ mononuclear cells at the site of
replication of CPXV intratracheally or intradermally inoculated into mice
One possible cause for the differential persistence of CPXV versus
CPXVΔcrmA in ear pinnae as compared to a similar presence of both
viruses in the lungs of infected mice would be disparities in number
of anti-viral inﬂammatory cells inﬁltrating into these tissues.
Although we were unable to discriminate between subpopulations
of cytotoxic and antigen-presenting cells by immunohistochemical
means, this process was successful for the overall identiﬁcation of
T cells based on their CD3+ status. Accordingly, the mobilization of
this type of cell into sites of CPXV infection was examined
temporally (Fig. 6). No signiﬁcant difference was observed in the
number of CD3+ mononuclear cells within the lungs of CPXV-
infected mice compared to CPXVΔcrmA-infected mice at any time
point (Fig. 6A). In contrast to the i.t.-inoculated mice, a signiﬁcantly
greater accumulation of CD3+ cells was noted at the dermal site of
CPXVΔcrmA replication as compared to that for the wt virus at 8 dpi
(Fig. 6B). The increased number of CD3+ cells associated with the
CPXVΔcrmA infection may account for enhanced clearance of this
virus 8 days later (Fig. 5).
Discussion
One of the goals of this work is to formally present and endorse the
i.t. small animal respiratory model of Orthopoxvirus infection and to
further emphasize the necessity to evaluate more than one modeld ear pinnae (B) after inoculation with PBS, CPXV, or CPXVΔcrmA. Error bars represent
.008.
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modulators or other virulence factors. The i.t. model of CPXV
inoculation reproducibly caused lesions consistent with viral bronch-
opneumonia; these lesions are consistent with the terminal symp-
toms we observed and are the cause of death of infected mice. The
inoculum volume that we used (30 μL) is approximately 18% of the
mean tidal volume of a 5-week-old mouse (Fairchild, 1972) and was
well tolerated with minimal signs of respiratory distress or reﬂux of
ﬂuid. Histological lesions in the lungs were evenly distributed among
lung lobes which suggests that i.t. inoculation improves distribution of
ﬂuid throughout the lungs compared to i.n. administration. The i.t.
route allows a precise dose of virus to be introduced into the
respiratory tract with little involvement of the nasal cavity resulting in
more animal to animal consistency. This procedure also greatly
reduces or eliminates death due to rhinitis and sinusitis (which are
often unintended sequelae of i.n. infection). Intratracheal inoculation
also results in a lower dose of CPXV required to cause severe disease
by 100-fold when compared to i.n. infections (3.2×103 pfu/mouse i.t.
compared to 2×105 pfu/mouse i.n.). Hence we believe that the i.t.
route of inoculation of mice with CPXV and other Orthopoxviruses
provides an effective, sensitive, and reproducible model of pulmonary
Orthopoxvirus infection and is superior to the i.n. model.
The somewhat increased survival rate and reduction of clinical
signs observed in mice infected i.t. with CPXVΔcrmA compared to
CPXV-infected mice indicate that crmA makes some contribution to
virulence during pulmonary infection of C57BL/6 mice. Although
survival datawith rCPXV did not precisely equal results with wt CPXV,
the differences were not statistically signiﬁcant and clinical signs
indicated the virulence of rCPXV and CPXV were similar. The increase
in survival rate with CPXVΔcrmA agrees with overall results observed
after i.n. infection with CPXV deleted for crmA in BALB/c mice
(Thompson et al., 1993) and VACV deleted for SPI-2 (crmA) in BALB/
c×C57BL/6 mice (Legrand et al., 2004). However, following i.t.
inoculation, CPXVΔcrmA attenuation was modest and observable
only within a narrow dose range; doses lower than 103 pfu/mouse did
not cause signiﬁcant disease signs in CPXV- or CPXVΔcrmA-infected
mice and doses greater than 5×104 pfu/mouse caused severe disease
in both experimental groups. This limited window of differential
susceptibility may explain the lack of attenuation reported in studies
with i.n. VACV deleted for SPI-2 in BALB/c mice (Kettle et al., 1995).
In the i.t. model, the severity of pulmonary inﬂammation
correlated to severity of clinical symptoms but no quantitative
differences were found in virus titer, number of apoptotic cells, or
number of CD3+ cells in lesions when CPXV- and CPXVΔcrmA-infected
mice were compared. This ﬁnding is in contrast to a recent study
showing that i.n. inoculation with the VACV Western Reserve (WR)
strain causes slightly decreased numbers of CD3+ mononuclear cells in
the animals' lungs compared to infection with the attenuated Wyeth
strain (Hayasaka et al., 2007); although this comparison should be
made with caution given the fact that VACV Wyeth is known to be
attenuated and contains several uncharacterized genetic mutations.
The i.d. route of infection using the ear pinnae as the site for
introduction of virus was also examined in this study. Intradermal
infection of mice with CPXVΔcrmA was attenuated compared to
infection with CPXV, similar to what was observed during i.t.
inoculation. Interestingly, i.d. infectionwith CPXV caused more severe
inﬂammation at the site of inoculation throughout the time course of
disease, but the number of inﬁltrating CD3+ cells was decreased by
8 dpi compared to CPXVΔcrmA-infected mice. This result parallels
that observed after i.n. inoculation of VACV WR and VACV Wyeth
(Hayasaka et al., 2007). The increase in CD3+ cells in the ear pinnae of
animals infected with CPXVΔcrmA likely contributed to the more
rapid clearance of virus in these mice compared to animals infected
with CPXV. This ﬁnding strongly supports the use of more than one
route of inoculation to determine the effects of deletion of various
poxvirus genes.Recent studies, which established i.d. inoculation of BALB/c mice as
a model of poxvirus pathogenesis, showed that injection of 106 pfu
VACV caused smaller primary lesions than CPXV or VACVΔSPI-2,
indicating that VACVΔSPI-2 was not attenuated in this model
(Tscharke et al., 2002). It was supposed that the increased inﬂamma-
tory response observed after i.d. infection with VACVΔSPI-2 was due
to the lack of SPI-2 inhibition of pro-inﬂammatory caspase-1. The
opposing results in that study and ours may be due to the different
mouse strains used, but differences between VACV and CPXV
pathogenesis or differences in activity or speciﬁcity of the homologues
SPI-2 and crmA must also be considered.
To further characterize the differences observed during i.t. CPXV
and CPXVΔcrmA infection, we evaluated the effect of crmA deletion
on cytokine levels to determine if crmA limited IL-1β and IL-18
processing. Themild increases observed in IL-1β and IL-18 levels were
unlikely to be physiologically signiﬁcant at any time point during
infection with either CPXV or CPXVΔcrmA. This is consistent with the
ﬁnding that i.n. inoculation with VACV deleted for SPI-2 did not cause
IL-1β-induced fever but VACV deleted for the soluble IL-1β receptor
did (Kettle et al., 1997). It is most likely that, even the absence of crmA,
IL-1β and IL-18 levels are controlled by soluble IL-1β receptor, IL-18
binding protein, and other redundant immunomodulatory proteins
encoded by CPXV and CPXVΔcrmA. Several additional cytokines and
chemokines that are typically increased during inﬂammation were
also maintained at low levels during CPXV and CPXVΔcrmA infection.
CPXV encodes virulence proteins that could downregulate most of the
mediators normally increased during an inﬂammatory process.
The cytokines and chemokines that were present at increased
levels in sera of infected mice from 7 to 9 dpi were IL-6, IL-10, and KC.
This agrees in part with Knorr et al. (2006) whom reported increases
in serum IL-6, IL-10, and granulocyte/macrophage colony stimulating
factor (GM-CSF) 6 days after i.n. inoculation of BALB/c mice with
3×105 pfu CPXV. However, we did not observe an increase in GM-CSF
using the Bio-Rad Mouse Cytokine 18-plex Panel and the Panomics
TranSignal Mouse Cytokine Antibody Array used by Knorr et al. (2006)
does not detect KC. There are no known CPXV-encoded proteins that
directly control levels of IL-6, IL-10, or KC. All three of these
immunomodulators would be expected to be increased during severe
virus-induced inﬂammation and necrosis. The relative increase in
serum IL-6, IL-10, and KC during CPXV infection (compared to
CPXVΔcrmA infection) is reﬂective of the more severe necrosis and
inﬂammation caused by CPXV.
It is difﬁcult to speculate why interleukin levels in lung homo-
genates did not parallel serum cytokine levels more precisely. Again,
the relative increase in IL-6 and KC during CPXV infection compared to
CPXVΔcrmA mirrors the disease severity observed with CPXV
infection. However, the control of IL-10 in infected lungs cannot be
explained by this line of thought. The ﬂow-based multiplex bead array
method has been compared to standard ELISAs; comparable patterns
of cytokine levels were reported with both assays, however absolute
values varied with the manufacturer of the assay (Khan et al., 2004).
Ultimately, the levels of all cytokines and chemokines tested were
remarkably low, given the amount of inﬂammation observed in
infected lungs, which indicates CPXV can control the levels of immune
mediators present during infection. Interestingly, VACV is not able to
prevent increases in interferon-γ (IFN-γ), tumor necrosis factor-α
(TNF-α), nitric oxide, monocyte chemotactic protein-1 (MCP-1), MIP-
1α, eotaxin, KC, or MIP-2 in BAL ﬂuid during i.n. infection of BALB/c
mice (Reading and Smith, 2003). This may indicate that CPXV
immunomodulatory proteins are better adapted to inhibit the mouse
immune system than VACV proteins; the larger genome size of CPXV
compared to VACV likely contributes to the inherently increased
immunomodulatory function of CPXV. However themouse strain used
may have made a signiﬁcant difference in the host immune system
response to virus infection. The minimal increase in all cytokines and
chemokines tested also suggests that CPXV produces virulence factors
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disrupt control of the majority of immune mediators tested.
We were also unable to see any effect of crmA on the number of
apoptotic cells in the lungs and mediastinal lymph nodes of i.t-
inoculated animals or in themandibular lymph nodes draining the ear
pinnae of i.d-inoculated animals. This result was surprising because
crmA is necessary to control apoptosis in infected chicken chorioal-
lantoic membranes (Nathaniel et al., 2004). However, embryonated
chicken eggs have an intact innate immune response, but have not yet
developed a cell-mediated immune response (Chen et al., 1994;
Masteller et al., 1997). It is likely that control of apoptosis is not as
critical in animal models with a rapid cell-mediated immune
response, such as the mouse.
In conclusion, i.t. inoculation of 104 pfu CPXV in mice causes a
reproducible severe pulmonary disease which mimics smallpox-
induced pneumonia in humans. Deletion of crmA from CPXV caused
some attenuation in the i.t. mouse pulmonary disease model and as
well as after i.d. inoculation. In the both models, inﬂammation
observed in H&E-stained tissue sections corresponded to the severity
of disease signs and was not increased, as predicted, during
CPXVΔcrmA infection. Virus growth was not signiﬁcantly affected by
crmA deletion after i.t. inoculation of virus, but it was cleared by
16 days after i.d. infection. An increase in the CD3+ mononuclear cell
population was seen in ear pinnae 8 dpi and likely contributed to the
more rapid clearance of virus from mice infected with CPXVΔcrmA.
The mechanism by which crmA inhibits inﬁltration of CD3+ cells
remains unclear. It would be interesting to determine whether crmA
mediates small changes in cytokine levels at the site of an i.d. infection




African green monkey kidney (CV-1) ﬁbroblasts and LLC-PK1 cells
were obtained from the American Type Culture Collection (ATTC CCL-
70 and CL-101 respectively). CV-1 cells were maintained in minimum
essential medium (MEM) with Earle's salts and LLC-PK1 cells in
medium 199 (GIBCO, Grand Island, NY), both supplemented with 5%
fetal bovine serum (GIBCO), 2 mM glutamine, 50 U/mL penicillin G,
50 μg/mL streptomycin, 1 mM sodium pyruvate, and 0.1 mM
nonessential amino acids (Mediatech, Herndon, VA) and incubated
at 37 °C in a 5% CO2 atmosphere with 100% humidity. Three viruses
were used in this study: the wild type Brighton Red strain of cowpox
virus (CPXV) was obtained from David Pickup (Duke University
Medical Center, Durham, NC, U.S.A.); a crmA-deﬁcient derivative of
CPXV (CPXVΔcrmA) [originally designated CPVΔcrmA::lacZ (Natha-
niel et al., 2004)]; and a rescue mutant (rCPXV). Rescued CPXV was
generated from CPXVΔcrmA in the following manner. First, a 1682 bp
region encompassing the crmA ORF and approximately 300 nucleo-
tides of upstream and downstream ﬂanking DNA was ampliﬁed from
the CPXV genome by using forward primer FS1 (GGTTCGGTGGCAAA-
CTTTCCATGG), reverse primer FS43 (CGCGAACGTCGATGAACACTGA-
TTCCGCATC), and Vent polymerase (New England Biolabs, Ipswich,
MA). After conﬁrmation of its nucleotide sequence, 2 μgof the amplicon
were transfected in the presence of Lipofectamine (Invitrogen,
Carlsbad, CA) and 1 μg of CPXVΔcrmA DNA into CV-1 cells previously
inoculated for 1 h with CPXVΔcrmA at a multiplicity of infection (moi)
of 0.05. Progenywere screened for insertion of the crmA gene based on
their inability to hydrolyze 5-bromo-4-chloro-3-indolyl-D-galactoside
(X-gal) present inmedia added to the agarose overlays of infected CV-1
monolayers. After four rounds of plaque-puriﬁcation, the rCPXV was
passed once in CV-1monolayers. The insertion of the crmAORF into the
genome of the rescue virus was veriﬁed by nucleotide sequence
analysis of the relevant region and the use of immunoblotting todemonstrate the presence of crmA in the lysate of infected CV-1 cells as
described previously (Nathaniel et al., 2004).
Terminal caspase activity assays
Monolayers of LLC-PK1 cellsweremock-treated or infected at amoi
of 10 with CPXV, CPXVΔcrmA, or rCPXV. At 15 hpi, the cells were
harvested, concentrated by centrifugation at 2000 ×g for 10min at 4 °C,
and resuspended in 100 μL 10 mM HEPES pH 7.5, 2 mM EDTA, 0.1%
CHAPS, and 1mMDTT. The cell suspensionwas frozen/thawed 4 times
and clariﬁed at 5000 ×g for 15 min at 4 °C. Terminal caspase activity in
5 μg of proteinwas measured as previously described (Nathaniel et al.,
2004). The rates of cleavage observed in four independent infections
with each virus were averaged and compared to the average rate of
cleavage from four mock-treated (uninfected) cells.
Intratracheal inoculation of mice
Groups of ﬁve or more 5-week-old female C57BL/6 speciﬁc-
pathogen-free (spf) mice (The Jackson Laboratory, Bar Harbor, ME)
were infected with sequential 10-fold dilutions of CPXV or
CPXVΔcrmA from 105 to 103 pfu of virus to determine the effective
lethal dose of 50% of themice (eLD50). This parameter is deﬁned as the
quantity of virus that would cause sufﬁciently severe respiratory
distress in half of the respective infected mice to necessitate their
euthanasia and was calculated according to the Reed and Muench
formula (Reed and Muench, 1938). The largest difference between the
eLD50s of CPXV and CPXVΔcrmA was observed at a dose of 104 pfu/
mouse, so this dose was chosen for the remainder of the experiments.
Three experimental groups of mice were combined to obtain survival
rates after infection. Four additional experimental groups were used
for organ histopathology and cytokine levels in BAL ﬂuid and blood.
Two of the experimental groups were used to collect lung for ELISAs
over a time course of infection. Two experimental groups were used
for virus isolation from organs. The number of mice used for each
experiment with each virus and each time point varied from 3 to 10
mice per group.
For all experiments, mice were anesthetized with isoﬂurane gas or
by intraperitoneal (i.p.) injection of a combination of 80 to 90 mg/kg
ketamine HCl and 12 to 15 mg/kg xylazine diluted in sterile isotonic
sodium chloride. The mice were placed in a supine position and the
skin at the ventral aspect of the throat was surgically prepared. A
0.5 cm incision was made on the ventral aspect of the throat and a
sterile microchip that transmitted a numeric identiﬁcation for each
mouse along with body temperature (BioMedic Data Systems, Inc.,
Seaford, DE) was inserted under the skin to the left of the thorax over
the pectoral muscles. The trachea was carefully exposed by blunt
dissection and 30 μL of diluted virus or PBS was injected i.t. through a
30 gauge needle. The surgical wound was closed with either a sterile
surgical clip or sterile tissue glue. Animals weremonitored twice a day
for up to 23 days.
For non-survival experiments, at the appropriate times post
inoculation, animals were anesthetized as described above. The axial
artery was severed with scissors to collect blood then mice were
euthanized by i.p. injection of 150 mg/kg sodium pentobarbital
(Schering-Plough Animal Health, Union, NJ). A BAL sample was
collected at the time of death and a complete necropsy was
preformed. Organs were placed in 10% buffered formalin (Protocol;
Fisher Scientiﬁc, Kalamazoo, MI) for histopathological examination
and immunohistochemical analysis or they were ﬂash-frozen in liquid
nitrogen for virus isolation and evaluation of cytokine levels by ELISA.
Intradermal inoculation of mice
Three to ﬁve 5-week-old female C57BL/6 spfmicewere infected i.d.
in their left ear pinnea with 50 μL of PBS containing sequential 10-fold
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The largest difference in CPXV and CPXVΔcrmA pathogenesis was
observed at 105 pfu/mouse. Therefore, for subsequent experiments,
each animal received 105 pfu virus i.d. In all cases, the left ear pinna of
each mouse was infected with virus while the right ear was injected
with PBS to serve as a negative control site. Gross pathology of ear
pinnae were scored based on the following numerical system:
1=redness; 2=ulcers/scab; and 3=redness+ulcers/scab. Scores for
treatment were summed and divided by the maximum, obtainable
value (number of mice in group×3) to provide an average clinical
score. A separate control group of mice that did not receive any virus,
but were injected with PBS in both ears, were included for
experiments that utilized ﬂow cytometry to identify cell subsets in
lymph nodes.
Prior to i.d. inoculation, the mice were anesthetized with
isoﬂurane gas and their ear pinnae wiped with 70% ethanol. The ear
pinna were then gently extended away from the head and PBS
containing or lacking virus was injected at the base of the left or right
ear, respectively, between the dorsal and ventral aspects of the pinna
using a 30 gauge needle. Animalsweremonitored twice a day for up to
26 days.
At the appropriate times post inoculation, micewere euthanized as
described above. Ear pinnaewere removed and placed in 10% buffered
formalin (Protocol; Fisher Scientiﬁc) for future histopathological
analysis (n=9 per group) or ﬂash-frozen for later virus titration
(n=3 to 11 mice per group). Spleen, mandibular lymph nodes, and
inguinal lymph nodes were collected for cell identiﬁcation by ﬂow
cytometric analysis and cytology or for histopathology. Samples from
three mice were pooled to ensure enough cells were recovered for
ﬂow cytometry. The lymphoid organs were diced in PBS using two 30
gauge needles. The resulting cell suspension was ﬁltered through a
70 μm Nylon membrane (BD Biosciences, Bedford, MA) into 50 mL
conical tubes. Flow cytometry results from three sets of experimental
groups were averaged.
Virus isolation from mice
Tissue collected from animals was ﬂash-frozen in liquid nitrogen
and stored at −80 °C until they were processed. Tissues were weighed
and 1 mL of PBS was added to each sample. The samples were
disrupted using a MiniBeadbeater-8 (BioSpec Products, Inc., Bartles-
ville, OK), diluted 1:100 in media without serum, and sonicated.
Monolayers of CV-1 cells were inoculated with serial dilutions of the
organ samples and plaque assays were performed to determine virus
titer.
TUNEL of apoptotic cells from CPXV-infected mice
The ApopTag Apoptosis Detection Kit (Chemicon International,
Inc., Temecula, CA) was used to perform TUNEL assays on depar-
afﬁnized sections of lung and mediastinal lymph nodes of C57BL/6
mice i.t.-infectedwith 30 μL PBS alone or containing 104 pfu of CPXV or
CPXVΔcrmA. Samples were stained following the manufacturer's
protocol. Upon completion of the procedure, the sectioned tissue was
stored in the dark at −20 °C until analyzed during the subsequent 12 h
by ﬂuorescent microscopy.
Determination of chemokine and cytokine levels in serum and
BAL samples
Sera and BAL ﬂuid were collected from C57BL/6 mice infected
i.t. with 30 μL PBS alone or containing 104 pfu of CPXV or
CPXVΔcrmA. Levels of eighteen chemokines and cytokines [IL-1α,
IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12 subunit p40, IL-12
subunit p70, IL-17, IFN-γ, TNF-α, MIP-1α (CCL3), the regulation on
activation normal T expressed and secreted protein (RANTES, CCL5),KC (Gro-1, Gro-α, CXCL1), granulocyte colony stimulating factor
(G-CSF), and GM-CSF] were quantiﬁed in each sample by using the
Mouse Cytokine 18-plex Panel in a Bio-Plex Multi-Plex Cytokine
Assay (Bio-Rad Laboratories) according to manufacturer's instruc-
tions for pre-mixed multiple assays. A Bio-Plex Diluent Kit for
mouse serum samples was used as directed to dilute serum samples
(1:4) and kit standards. BAL samples were not diluted. Standards for
BAL samples were diluted in PBS.
Determination of chemokine and cytokine levels in lung tissue
Liquid nitrogen-frozen samples of lung tissue from i.t.-inoculated
C57BL/6micewere placed into 17×100mm centrifuge tubes (Corning,
Inc., Acton, MA) and 5 weight-volumes of cold PBS was added to each
sample (n=4 to 5 mice per experimental group). Samples were
homogenized for 1 min with a Polytron homogenizer (Glen Mills Inc.,
Clifton, NJ) then centrifuged for 10 min at 4 °C and 10,000 rpm
(Beckman J2-H5). The supernatant was collected and stored at −80 °C
until assayed for the presence of IL-1β, IL-18, IL-6, IL-10, and KC by the
use of commercially available ELISAs.
Identiﬁcation of cell subsets in lymphoid tissues
Samples collected for cytology and ﬂow cytometry were centri-
fuged at 400 ×g and 4 °C for 5 min. The supernatant was removed and
cell pellets from inguinal lymph node samples were resuspended in
cold Hanks azide buffer (HAB) adjusted to pH 7.4 [Hanks balanced salt
solution without Ca2+ or Mg2+ (JRH Biosciences, Inc., Lenexa, KS), 1%
bovine serum albumin, 0.1% NaN3, 1 mM EDTA]. Cell pellets from the
spleen and mandibular lymph nodes were ﬁrst resuspended in 0.84%
NH4Cl for 5min on ice to lyse red blood cells, centrifuged as above, and
then resuspended in cold HAB. The number of cells collected from
each sample was determined using a hemocytometer.
Approximately 2×106 cells from each sample were placed in
12×75 mm polystyrene tubes (Fisher Scientiﬁc Co., Pittsburg, PA) for
ﬂow cytometry. Cells were washed in HAB, centrifuged as above, and
then resuspended in 100 μL 4% HAB (HAB plus an additional 3% bovine
serum albumin) and 2 μL Mouse Fc Block (BD Biosciences, San Jose,
CA). These samples were incubated in the dark for 10 min at RT. The
appropriate ﬂuorescent dye-conjugatedmonoclonal antibodies (mAb;
BD Biosciences) were added to each tube. Samples were incubated
with the antibodies in the dark at RT for 15 min. Cells were pelleted as
above and ﬁnally resuspended in 500 μL HAB and 5 μL 7-AAD (BD
Biosciences).
Flow cytometry was performed using a FACSCalibur four color
analyzer (BD Biosciences). BD CellQuest Pro Software for Mac OSX
was used to acquire and analyze the ﬂow cytometry data. To
establish ﬂow cytometric parameters, splenocytes were incubated
with isotype controls for each antibody. Splenocytes also were
incubated with rat anti-mouse CD8a mAbs conjugated to the
appropriate ﬂuorochromes (BD Biosciences) to compensate for
overlap of emission wavelengths detected by the ﬂow cytometer.
The total number of CD4+ cells (helper T cells), CD8+ cells (cytotoxic
T cells), natural killer (NK, NK1.1+/CD49b+) cells, and NKT (NK1.1+/
CD3+) cells was determined for each experimental group at 4, 8,
and 16 dpi. Activation of these cells, excluding NKT cells, also was
determined. Analysis of activated CD4+ and CD8+ cells was done by
identifying the cells in these subsets that were double positive for
CD25 and CD69. The number of activated NK cells was determined
from the number of CD25+ cells that were also NK1.1+. Data from
each cell type examined (except apoptotic cells) were gated on cell
size to remove cell fragments and on 7-AAD. 7-AAD positive cells
were considered dead cells and were not included in the analysis.
Apoptotic helper and cytotoxic T cells were analyzed using Annexin-
V-FITC (Apoptosis Detection Kit I, BD Biosciences). As a positive
control for apoptosis, 100 μM staurosporine (Sigma Chemical, St.
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mice for 4 h prior to incubation of the cells with Mouse Fc Block.
Staurosporine-treated cells were then processed as described above.
Identiﬁcation of CD3+ cells in the lungs and ear pinnae
Staining of CD3+ cells in sections of formalin-ﬁxed lungs from
C57BL/6 mice i.t.-inoculated with PBS alone or 104 pfu CPXV or
CPXVΔcrmA or ear pinnae from animals i.d. injected with PBS or 105
pfu of virus was performed by the Histopathology Section of the
Veterinary Diagnostic Laboratory at the University of Illinois (Urbana,
IL). Cells reactive with a rabbit polyclonal anti-human CD3 antibody
(Dako, Carpinteria, CA) were identiﬁed by using light microscopy
(100× magniﬁcation).
Statistics
Survival data was analyzed using PROC GENMOD in SAS 9.1 to
perform a logistic regression of the data. Analysis of differences in
virus titers, cytokine levels, and number of lymphocyte subsets was
conducted using a mixed model analysis program, PROC MIXED, in
SAS 9.1. The ability to isolate virus after infection with CPXV or
CPXVΔcrmAwas compared using a Fisher's exact test. The numbers of
CD3+ cells in infected tissues was evaluated by ANOVA using MedCalc
version 9.5.1.0.
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